The feasibility of 18F-Fluoromisonidazole (18F-FMISO) imaging for atherosclerotic and non-atherosclerotic intra-arterial hypoxia.
- Conditions
- Cardiovascular DiseasePeripheral artery diseaseCardiovascular - Other cardiovascular diseasesArterial calcificationCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
- Registration Number
- ACTRN12622000442707
- Lead Sponsor
- Royal Perth Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 12
Male or post-menopausal female (defined as the absence of menses of >12 months in the absence of pathology) above the age 40 who have undergone a clinical decision to proceed to below knee or above knee amputation
-A lower limb computed-tomography angiography performed in the last 18 months and performed exclusively for clinical purposes
-Have some evidence of arterial disease on lower limb computed-tomography angiography
-Inability to provide informed consent
-A diagnosis of chronic obstructive pulmonary disease or other respiratory disease that currently requires home oxygen therapy
-A resting oxygen saturation (measured at time of screening and in the absence of oxygen therapy) below 92%
-eGFR less than or equal to 30 at time of screening
-Symptomatic heart failure impairing an ability to lie flat on for imaging purposes or requiring supplemental oxygen therapy
-A prior below knee, above knee or higher, lower limb amputation of the other limb
-Acute lower limb ischemia requiring urgent revascularisation or emergent amputation
-Prior orthopaedic surgery of the lower limb with foreign material remaining in-situ
-In-patients requiring nurse escort for inter-hospital transport
-Recent or current lung cancer or cancer of the lower limb (excluding Non-melanoma skin cancer)
-Known cardiac arrhythmia that precludes ECG gating
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method